Trial site
Shenzhen Geno-immune Medical Institute
- 33running trials
- 22closed trials
The trials here
What the 55 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers36 trials
- Acute lymphoblastic leukaemia6 trials
- Acute myeloid leukaemia5 trials
- Multiple myeloma4 trials
- Chronic lymphocytic leukaemia3 trials
- Ovarian cancer3 trials
- Cervical cancer2 trials
- Glioblastoma2 trials
- Haemophilia2 trials
- Melanoma2 trials
- Prostate cancer2 trials
- Sarcoma2 trials
- and 9 more
- Phase
- Phase 1/242 trials
- Phase 111 trials
- Status
- Not yet recruiting32 trials
- Terminated22 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Shenzhen Geno-Immune Medical Institute55 trials
Running trials
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
SCID-X1 Gene Therapy Via Intravenous Lentiviral (Ivlv-X1) Injection
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Gene Therapy of Beta Thalassemia Using a Self-inactivating Lentiviral Vector
Not yet recruiting
4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma
Not yet recruiting
Not yet recruiting
Frontline Combination CAR-T Cell Therapy for Multiple Myeloma or Plasmacytoma
Not yet recruiting
Not yet recruiting
Multi-CAR T Cell Therapy in the Treatment of Multiple Myeloma
Not yet recruiting
Not yet recruiting
Not yet recruiting
Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies
Enrolling by invitation
Intervention of Ovarian Cancer With Antigen-specific Engineered Immune Effectors
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers21 recruiting
- Acute myeloid leukaemia4 recruiting
- Multiple myeloma4 recruiting
- Acute lymphoblastic leukaemia3 recruiting
- Haemophilia2 recruiting
- Sarcoma2 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- COPD1 recruiting
- Glioblastoma1 recruiting
- Lung cancer1 recruiting
- Melanoma1 recruiting
- Neuroblastoma1 recruiting
- Ovarian cancer1 recruiting
- Prostate cancer1 recruiting
- Thalassaemia1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Terminated
Terminated
Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections
Terminated
HPV Specific Immune Lymphocytes (HPV-CTLs) in the Treatment of HPV
Terminated
Terminated
NGS-MRD Assessment of Combination Immunotherapies Targeting T-ALL
Terminated
Terminated
NGS-MRD Assessment of Combination Immunotherapies Targeting B-ALL
Terminated
Terminated
Terminated
Terminated
Terminated
Terminated
Terminated
Terminated
Combination CAR-T Cell Therapy Targeting Hematological Malignancies
Terminated
Terminated
Terminated
Immunotherapy Based on Tumor Associated Antigen-specific Immune Effector Cells
Terminated
Terminated
Terminated
Terminated
Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme
Site data: ClinicalTrials.govUpdated 17 Nov 2026